Showing results (1-10 of 67) with videos related to
Sort By:
Pageof 7
International Reviews of Immunology|June 25, 2008
The two-faced NF-kappaB in the skinInderpreet Sur, Maria Ulvmar, Rune ToftgårdJournal of Receptor and Signal Transduction Research|June 13, 2009
Inhibition of NF-kappaB signaling interferes with phorbol ester-induced growth arrest of keratinocytes in a TNFR1-independent mannerInderpreet Sur, Maria Ulvmar, Roger Jungedal, et al.European Journal of Cell Biology|July 13, 2002
Human Krüppel-like factor5/KLF5: synergy with NF-kappaB/Rel factors and expression in human skin and hair folliclesInderpreet Sur, A Birgitte Undén, Rune ToftgårdArchives of Dermatological Research|March 17, 2004
Involvement of RFX proteins in transcriptional activation from a Ras-responsive enhancer elementSusann Maijgren, Inderpreet Sur, Mats Nilsson, et al.The Journal of Investigative Dermatology|June 12, 2009
Timed NF-kappaB inhibition in skin reveals dual independent effects on development of HED/EDA and chronic inflammationMaria H Ulvmar, Inderpreet Sur, Sylvie Mémet, et al.Journal of Cell Science|August 17, 2006
Epidermal and craniofacial defects in mice overexpressing Klf5 in the basal layer of the epidermisInderpreet Sur, Björn Rozell, Viljar Jaks, et al.Transgenic Research|June 12, 2021
Severe liver disease resembling PSC in mice with K5-Cre mediated deletion of Krüppel-like factor 5 (Klf5)Åsa Bergström, Marco Gerling, Noémi Van Hul, et al.Proceedings of the National Academy of Sciences of the United States of America|March 27, 2004
Tumor necrosis factor receptor 1-mediated signaling is required for skin cancer development induced by NF-kappaB inhibitionMaria H Lind, Björn Rozell, Robert P A Wallin, et al.Current Opinion in Investigational Drugs (London, England : 2000)|July 12, 2007
The Hedgehog pathway as a drug target in cancer therapyMatthias Lauth, Rune ToftgårdPageof 7